On March 17, 2014, Cardium Therapeutics, Inc. changed its name to Taxus Cardium Pharmaceuticals Group Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% |
|
-.--% | -.--% |
2022 | Gene Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
2021 | Gene Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 64 | |
+16.59% | 44.44B | |
-9.89% | 37.99B | |
+35.68% | 37.75B | |
+27.12% | 30.78B | |
-8.64% | 27.38B | |
+11.81% | 26.17B | |
+45.08% | 14.15B | |
+32.85% | 12.59B | |
-7.19% | 11.28B |
- Stock Market
- Equities
- CRXM Stock
- News Gene Biotherapeutics, Inc.
- Cardium Therapeutics, Inc. has Changed its Name to Taxus Cardium Pharmaceuticals Group Inc